isomethyleugenol has been researched along with Ependymoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; He, X; Jia, Y; Kang, E; Wang, G; Wang, J; Ye, Y | 1 |
| Guo, S; Huang, J; Jiang, W; Wang, J; Wang, L; Xie, Y; Xu, F; Zhang, C | 1 |
| Bortolotto, S; Bosone, I; Cavalla, P; Chiadò-Piat, L; Mauro, A; Schiffer, D | 1 |
3 other study(ies) available for isomethyleugenol and Ependymoma
| Article | Year |
|---|---|
Identification of key methylation differentially expressed genes in posterior fossa ependymoma based on epigenomic and transcriptome analysis.
Topics: Child; Ependymoma; Epigenomics; Gene Expression Profiling; Humans; Methylation; Phosphatidylinositol 3-Kinases; Transcriptome | 2021 |
Detecting the long non‑coding RNA signature related to spinal cord ependymal tumor subtype using a genome‑wide methylome analysis approach.
Topics: Adult; Databases, Genetic; Ependymoma; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genome, Human; Humans; Methylation; Promoter Regions, Genetic; RNA, Long Noncoding; Signal Transduction; Spinal Cord; Spinal Neoplasms | 2019 |
CDKN2A/p16 in ependymomas.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Cell Nucleus; Child; Child, Preschool; Cyclin-Dependent Kinase Inhibitor p16; Ependymoma; Humans; Immunohistochemistry; Ki-67 Antigen; Methylation; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Deletion; Tissue Embedding | 2001 |